Nektar Therapeutics (NKTR) Profit After Tax: 2009-2024
Historic Profit After Tax for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to -$119.0 million.
- Nektar Therapeutics' Profit After Tax rose 4.14% to -$35.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$120.7 million, marking a year-over-year increase of 28.26%. This contributed to the annual value of -$119.0 million for FY2024, which is 56.91% up from last year.
- Per Nektar Therapeutics' latest filing, its Profit After Tax stood at -$119.0 million for FY2024, which was up 56.91% from -$276.1 million recorded in FY2023.
- In the past 5 years, Nektar Therapeutics' Profit After Tax ranged from a high of -$119.0 million in FY2024 and a low of -$523.8 million during FY2021.
- Over the past 3 years, Nektar Therapeutics' median Profit After Tax value was -$276.1 million (recorded in 2023), while the average stood at -$254.4 million.
- Its Profit After Tax has fluctuated over the past 5 years, first fell by 17.86% in 2021, then skyrocketed by 56.91% in 2024.
- Yearly analysis of 5 years shows Nektar Therapeutics' Profit After Tax stood at -$444.4 million in 2020, then fell by 17.86% to -$523.8 million in 2021, then climbed by 29.71% to -$368.2 million in 2022, then rose by 25.03% to -$276.1 million in 2023, then skyrocketed by 56.91% to -$119.0 million in 2024.